Home > Quotes > ATRA

Atara Biotherapeutics, Inc. Common Stock Quote & Summary Data

ATRA 
$17.46
*  
0.48
2.68%
Get ATRA Alerts
*Delayed - data as of May 3, 2016 14:25 ET  -  Find a broker to begin trading ATRA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ATRA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Atara Biotherapeutics, Inc. Common Stock Intraday Chart




News for ATRA

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 17.94 $ 65.5599
Low $ 16.77 $ 13.31

The current last sale of $17.46 is 31.18% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a clinical-stage biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation. We have two groups of product candidates: (a) allogeneic or third-party derived antigen-specific T-cells, and (b) molecularly targeted biologics. T-cells are a type of white blood cell. Cytotoxic T-cells, otherwise known as cytotoxic T lymphocytes, or CTLs, have been shown to have the ability to kill cancer cells. Our T-cell product candidates arise from a platform technology designed to produce off-the-shelf, partially human leukocyte antigen, or HLA, matched cellular therapeutics utilizing CTLs. We licensed rights to these product candidates from Memorial Sloan Kettering Cancer Center, or MSK, in June 2015.  ... More ...  

Risk Grade

Where does ATRA fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?